Andrew S. Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 125,000 shares at $8.89 ($1.1M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Seasonal sale ($1.1M) by Executive Vice President — this insider has traded AMRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AMRX | SELL | 2024-08-16 | $983K | — | Filing → |
| AMRX | SELL | 2023-08-15 | $242K | — | Filing → |
| AMRX | BUY | 2019-08-07 | $385K | — | Filing → |